About 164 results
Open links in new tab
  1. OZURDEX

    Injections into the vitreous in the eye, including those with OZURDEX ®, are associated with serious eye infection (endophthalmitis), eye inflammation, increased eye pressure, and retinal …

  2. HOW IT WORKS - Ozurdex

    Injections into the vitreous in the eye, including those with OZURDEX ®, are associated with serious eye infection (endophthalmitis), eye inflammation, increased eye pressure, and retinal …

  3. WHAT TO EXPECT - Ozurdex

    Injections into the vitreous in the eye, including those with OZURDEX ®, are associated with serious eye infection (endophthalmitis), eye inflammation, increased eye pressure, and retinal …

  4. OZURDEX® Resources for Your Practice | OZURDEX® for HCPs

    3 days ago · OZURDEX® (dexamethasone intravitreal implant) resources for practices and patients. Please see Important Safety Information and Prescribing Information.

  5. OZURDEX® for HCPs | Home

    OZURDEX ® is a corticosteroid indicated for the treatment of macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO).

  6. OZURDEX® Reimbursement Support | For HCPs

    OZURDEX ® is a corticosteroid indicated for the treatment of macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO).

  7. OZURDEX® Mechanism of Action | OZURDEX® for HCPs

    OZURDEX ® is a corticosteroid indicated for the treatment of macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO).

  8. Injections into the vitreous in the eye, including those with OZURDEX®, are associated with serious eye infection (endophthalmitis), eye inflammation, increased eye pressure, and retinal …

  9. About OZURDEX® | OZURDEX® for HCPs

    OZURDEX ® is a corticosteroid indicated for the treatment of macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO).

  10. OZURDEX® Clinical Efficacy in DME | OZURDEX® for HCPs

    OZURDEX ® is a corticosteroid indicated for the treatment of macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO).